#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute hepatic failure Acute on chronic liver failure B-cell small lymphocytic lymphoma Optic glioma Autologous haematopoietic stem cell transplant Chordoma Anti-neutrophil cytoplasmic antibody positive vasculitis B-cell small lymphocytic lymphoma recurrent Myeloid leukaemia Neuroendocrine cell hyperplasia of infancy Acute graft versus host disease in skin Lymphangiosarcoma Haematological malignancy Hypoxic-ischaemic encephalopathy Metastases to central nervous system More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung – Treatment Propionic acidaemia – Life with Disease Malignant fibrous histiocytoma – Diagnostics Chondrosarcoma – Basic Information Von Willebrand’s disease – Life with Disease Primary biliary cholangitis – Life with Disease Shprintzen-Goldberg syndrome Mantle cell lymphoma stage II – Trials in Disease Usher’s syndrome – Trials in Disease Ewing’s sarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zagociguat Sabatolimab Magnesium Oxide, Light Afimetoran Besilate Dihydrate Tavapadon Cipepofol Sxr1096 Cariprazine Pasireotide Diaspartate Human Albumin Solution Pyrazinamide Sodium Glycerophosphate Bomedemstat Regtivex Syn2 ALLERGEN EXTRACTS Certolizumab Pegol Dacarbazine Citrate Anhydrous Cidofovir Iti-1284 More therapies…

    Learn about Your Condition

    Cardiac amyloidosis Colorectal cancer stage IV Neuromuscular scoliosis Supraventricular tachycardia Peritoneal sarcoma Prostatitis Escherichia coli Eclampsia Burning mouth syndrome Appendicitis perforated Adrenocortical carcinoma Apathy Partial lipodystrophy Hypercholesterolaemia Thrombocytopenia Multifocal motor neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Brain Research Center Den Bosch B.V.

Brain Research Center Den Bosch B.V.

Statenlaan 37, s-Hertogenbosch, 5223 LA, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer’s Disease

    Not yet recruiting

    2 1
    Investigated Drugs:
    • D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
    Czechia France Germany Italy The Netherlands Poland +1

  • Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Czechia Denmark Finland +15

  • A study to evaluate the efficacy and safety of zenagamtide in people with obesity

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Belgium Bulgaria Denmark France Germany Italy +2

  • Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Florbetapir (18F)
    • Florbetaben (18F)
    • Florquinitau (18F)
    Denmark France Germany Italy The Netherlands Poland +1

  • A study testing MK-1167 added to current treatment in patients with mild to moderate Alzheimer’s disease dementia

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Mk-1167
    Italy The Netherlands Spain

  • A Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Gsk4527226
    Finland France Germany Italy The Netherlands Norway +2

  • Study on Donanemab, Florbetapir, and Flortaucipir for Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Donanemab
    • Florbetapir (18F)
    • Flortaucipir (18F)
    Czechia The Netherlands Poland

  • Study on the Effects of ALZ-801 in Patients Aged 50-80 with Early Alzheimer’s Disease and APOE4 Genotype

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Valiltramiprosate
    Czechia The Netherlands

  • Study on the Effects of Semaglutide in Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Florbetapir (18F)
    • Gsk4527226
    • Florbetaben (18F)
    Finland France Germany Italy The Netherlands Norway +2
Previous Page
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!